Ara
Toplam kayıt 3, listelenen: 1-3
Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
(Humana Press Inc, 2020)
As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined ...
Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era
(Hospital Clinicas, Univ Sao Paulo, 2020)